Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment

This study is to assess the clinical value of in vitro primary cell high-efficiency expansion and high-throughput drug sensitivity screening (HEHDS) system in leukemia, and we evaluated a cohort of 121 patients with acute myeloid leukemia (AML) and 27 patients with acute lymphoblastic leukemia (ALL)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lili, Wang, Wenliang, Liang, Li, Ge, Jian, Xia, Ruixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277151/
https://www.ncbi.nlm.nih.gov/pubmed/35845130
http://dx.doi.org/10.1155/2022/4052591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277151/
https://www.ncbi.nlm.nih.gov/pubmed/35845130
http://dx.doi.org/10.1155/2022/4052591

Ejemplares similares